%0 Conference Paper
%B Global Cardiovascular Clinical Trialists Forum
%C Washington DC, USA
%D 2016
%F AUS<br/>R&M<br/>FY17
%G eng
%T Diabetes type 2 CV outcome trials. Time to transition from non-inferiority safety to superiority efficacy trials? Session- Diabetes Outcome Trials. Transitioning to CV efficacy Trials [invited speaker]